Jiang Su Yida ChemicalLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 1/6
Jiang Su Yida ChemicalLtd has a total shareholder equity of CN¥1.2B and total debt of CN¥1.0B, which brings its debt-to-equity ratio to 84.1%. Its total assets and total liabilities are CN¥2.6B and CN¥1.3B respectively. Jiang Su Yida ChemicalLtd's EBIT is CN¥57.1M making its interest coverage ratio 1.3. It has cash and short-term investments of CN¥186.3M.
Anahtar bilgiler
84.1%
Borç/özkaynak oranı
CN¥1.05b
Borç
Faiz karşılama oranı | 1.3x |
Nakit | CN¥186.33m |
Eşitlik | CN¥1.24b |
Toplam yükümlülükler | CN¥1.35b |
Toplam varlıklar | CN¥2.59b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 42%
Oct 08There's Been No Shortage Of Growth Recently For Jiang Su Yida ChemicalLtd's (SZSE:300721) Returns On Capital
Sep 28Lacklustre Performance Is Driving Jiang Su Yida Chemical Co.,Ltd's (SZSE:300721) 25% Price Drop
Aug 12Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 36%
May 21Improved Revenues Required Before Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Stock's 41% Jump Looks Justified
Mar 08Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 300721's short term assets (CN¥712.8M) do not cover its short term liabilities (CN¥1.2B).
Uzun Vadeli Yükümlülükler: 300721's short term assets (CN¥712.8M) exceed its long term liabilities (CN¥98.4M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 300721's net debt to equity ratio (69.1%) is considered high.
Borcun Azaltılması: 300721's debt to equity ratio has increased from 55.3% to 84.1% over the past 5 years.
Borç Kapsamı: 300721's debt is not well covered by operating cash flow (13.8%).
Faiz Kapsamı: 300721's interest payments on its debt are not well covered by EBIT (1.3x coverage).